Kindly Medical (1501 HK) – Solid Growth Demonstrates a Rapid Recovery from COVID
Kindly’s major production base is in Jiading District, Shanghai which was seriously affected by the COVID lockdown during 2Q22.
167 Views
China Healthcare Weekly (Feb.19) - VBP on Biosimilar Drugs, Poor Performance of Healthcare Sector
This article analyzed the new document about VBP for biosimilar drugs, diabetes drugs market, support devices market in interventional fields,...
263 Views
Kangji Medical IPO: Trading Debut
Kangji Medical (9997 HK) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...
403 Views
Kangji Medical (康基医疗) IPO Trading: Ample Upsides as Peer Performed Well
Kangji Medical raised HKD 2.9 billion (USD 381 m) from its global offering and will list on the stock exchange next Monday. In our previous...
445 Views
Kangji Medical IPO: Valuation Insights
Kangji Medical (1498779D CH) is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China, with a 2.7%...
360 Views